Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Artel Smashes the SDI-to-IP Barrier with Game-Changing FiberLink™ ST2110-TD Throw-Down Units

March 19, 2026

Reply announces a partnership with Mistral AI to develop sovereign and enterprise-grade artificial intelligence solutions

March 19, 2026

BOOST Pharma Appoints Leading Biopharma Leader Elaine Jones as Chair

March 19, 2026

Sperra Deploys First 3D-Printed Concrete Gravity Anchor at EDP Floating Solar Test Site in Portugal

March 19, 2026

UpOnly Redefines How Crypto Assets Are Designed

March 19, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Global Medical Foam Market Forecast to 2028 – Rise in Demand for Sustainable Packaging Solutions in Healthcare and Emergence of New Foam Materials Creates Market Opportunities
Press Release

Global Medical Foam Market Forecast to 2028 – Rise in Demand for Sustainable Packaging Solutions in Healthcare and Emergence of New Foam Materials Creates Market Opportunities

By News RoomJanuary 8, 20246 Mins Read
Global Medical Foam Market Forecast to 2028 – Rise in Demand for Sustainable Packaging Solutions in Healthcare and Emergence of New Foam Materials Creates Market Opportunities
Share
Facebook Twitter LinkedIn Pinterest Email

Dublin, Jan. 08, 2024 (GLOBE NEWSWIRE) — The “Global Medical Foam Market by Form (Flexible, Rigid, Spray), Material (Polymers, Latex, Metals), Application (Bedding & Cushioning, Medical Packaging, Medical Devices & Components, Prosthetics & Wound Care), and Region – Forecast to 2028” report has been added to ResearchAndMarkets.com’s offering.

The global medical foam market will rise from USD 33 billion in 2023 to USD 43.3 billion by 2028 at a CAGR of 5.6% from 2023 to 2028. This growth can be attributed to the increasing aging population, the shift from traditional wound care products, the rise in global health care products, and the growth of the implantable device sector.

The bedding & cushioning segment is expected to hold the largest share of the medical foam market during the forecast period

The bedding & cushioning segment accounted for the largest share of the medical foam industry in 2022. Medical foam offers design flexibility, strength, and durability and is used in the construction of bedding & cushioning products such as mattresses, orthopedic supports, and pads. Medical foams have compression-relieving capabilities, which adapt to the patient’s body shape, thus providing comfort to patients. The growth of this segment can be attributed to the increase in the aging population and the rising construction of hospitals and medical centers across the globe.

Flexible foam is expected to be the largest segment of the medical foam market during the forecast period

The flexible foam segment is expected to be the largest in volume, owing to properties such as softness, moisture resistance, high impact & mechanical properties. Flexible foams regain their original shape even after being deformed. This property makes them suitable for use in bedding & cushioning products for patients to provide them with maximum comfort and support. Moreover, due to the ability to absorb shock, flexible foams are used in the packaging of medical devices and prosthetics.

Polymer segment is expected to lead the medical foam market during the forecast period

Based on material, the polymer segment is estimated to account for the largest share of the medical foam market in 2022 in terms of volume. The major types of polymer foam used in medical applications include polyurethane foam, polystyrene foam, polyolefin foam, and others. The growth of the polymer segment is due to the abundant availability, ease of manufacturing, and low cost compared to other materials. Foamed polymers possess properties such as low weight, heat preservation, sound absorption, biocompatibility, and excellent cushioning.

Asia Pacific is projected to grow at the highest CAGR of the medical foam market during the forecast period

The Asia Pacific medical foam industry has been studied for China, Japan, India, Indonesia, and the Rest of Asia Pacific. The Asia Pacific region presents an attractive market for medical foam due to shifting demographics and the rise in healthcare facilities and spending. Key industry leaders like Sekisui Chemical Co., Ltd. and INOAC Corporation have established manufacturing plants, distribution networks, and sales offices in the Asia Pacific area, ensuring a steady supply of medical foam.

These companies are also acquiring smaller firms and fabricators of medical foam in the region, contributing to market growth. Additionally, medical foam manufacturers from North America and Europe are expanding their presence in the Asia Pacific, fostering knowledge exchange between developed and emerging nations through active participation in various forums.

Market Dynamics

Drivers

  • Increase in Aging Population
  • Rise in Global Healthcare Expenditure
  • Growth of Implantable Devices Sector
  • Shift from Traditional to Advanced Wound Care Products

Restraints

  • Fluctuations in Raw Material Prices
  • Limited Biocompatibility and Compatibility Concerns

Opportunities

  • Rise in Demand for Sustainable Packaging Solutions in Healthcare
  • Emergence of New Foam Materials

Challenges

  • Stringent Rules & Regulations
  • Environmental and Sustainability Challenges

The report provides insights on the following:

  • Analysis of critical drivers (Rise in global healthcare expenditure), restraints (Fluctuations in raw material prices), opportunities (Rise in demand for sustainable packaging solutions in healthcare), and challenges (Stringent rules & regulations) influencing the growth of the medical foam market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities in the medical foam market.
  • Market Development: Comprehensive information about lucrative markets – the report analyses the medical foam market across varied regions.
  • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the medical foam market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like The Dow Chemical Company, Sekisui Chemical, Huntsman, Trelleborg, BASF, Recticel, INOAC, UFP Technologies, FXI Holdings, Armacell, Rogers Corporation, Freudenberg Group, Molnlycke Health Care and among others in the medical foam market.

Key Attributes:

Report Attribute Details
No. of Pages 295
Forecast Period 2023 – 2028
Estimated Market Value (USD) in 2023 $33 Billion
Forecasted Market Value (USD) by 2028 $43.3 Billion
Compound Annual Growth Rate 5.6%
Regions Covered Global

Key Topics Covered:

Executive Summary

  • Medical Foam: Market Snapshot, 2023 vs. 2028
  • Rigid Foam Segment to Lead in Terms of Value During Forecast Period
  • Bedding & Cushioning Segment to Lead Medical Foam Market During Forecast Period
  • Metal Foam Material to Lead Medical Foam Market During Forecast Period
  • Asia-Pacific to Witness Highest CAGR During Forecast Period

Premium Insights

  • Attractive Opportunities for Players in Medical Foam Market -Rise in Global Healthcare Expenditure and Growth of Implantable Devices Sector to Drive Growth
  • Medical Foam Market, by Region -Asia-Pacific to be Largest Regional Market
  • Medical Foam Market, by Form -Flexible Foam to Register Highest CAGR During Forecast Period
  • Medical Foam Market, by Application -Bedding & Cushioning to be Largest Application of Medical Foam
  • Medical Foam Market, by Type and Region -Asia-Pacific to Account for Largest Share of Medical Foam Market

Case Study Analysis

  • Use of Polyform Molded Foam Enhances Respiratory Device Performance
  • Maximizing Medical Product Excellence with Engineering Structural Foam at Brandon Medical

Companies Profiled

  • Armacell
  • BASF
  • Custom Foam Systems
  • Foam Techniques
  • Freudenberg
  • Future Foam
  • FXI Holdings
  • General Plastics Manufacturing Company
  • Huntsman Corporation
  • Inoac Corporation
  • Janco Inc.
  • Molnlycke Health Care
  • Polytag (Bela Tagra)
  • Porex
  • Recticel
  • Rogers
  • Rynel, Inc.
  • Sekisui Chemical
  • Shanghai Zhongwei New Materials
  • The Dow Chemical Company
  • The Woodbridge Group
  • Trelleborg
  • UFP Technologies
  • VIMTechnology
  • VPC Group
  • Wisconsin Foam Products

For more information about this report visit https://www.researchandmarkets.com/r/tirjs4

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

  • Global Medical Foam Market

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Artel Smashes the SDI-to-IP Barrier with Game-Changing FiberLink™ ST2110-TD Throw-Down Units

Reply announces a partnership with Mistral AI to develop sovereign and enterprise-grade artificial intelligence solutions

BOOST Pharma Appoints Leading Biopharma Leader Elaine Jones as Chair

Sperra Deploys First 3D-Printed Concrete Gravity Anchor at EDP Floating Solar Test Site in Portugal

UpOnly Redefines How Crypto Assets Are Designed

Kalmar and Yilport Oslo Terminal extend partnership with new order for electric reachstackers

WeRide Enters Slovakia, Launching Nation’s First Autonomous Driving Program with ELEVATE Slovakia

GLP-1 medications used to treat diabetes and obesity may also help alleviate symptoms of anxiety and depression

The Costigan Group at Compass Releases Data-Driven STR Framework for Nashville Investment Property Buyers

Editors Picks

Reply announces a partnership with Mistral AI to develop sovereign and enterprise-grade artificial intelligence solutions

March 19, 2026

BOOST Pharma Appoints Leading Biopharma Leader Elaine Jones as Chair

March 19, 2026

Sperra Deploys First 3D-Printed Concrete Gravity Anchor at EDP Floating Solar Test Site in Portugal

March 19, 2026

UpOnly Redefines How Crypto Assets Are Designed

March 19, 2026

Latest News

Kalmar and Yilport Oslo Terminal extend partnership with new order for electric reachstackers

March 19, 2026

WeRide Enters Slovakia, Launching Nation’s First Autonomous Driving Program with ELEVATE Slovakia

March 19, 2026

GLP-1 medications used to treat diabetes and obesity may also help alleviate symptoms of anxiety and depression

March 19, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version